Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease is a research paper published in Cells (2021). On theSindex it has a DataRank of 0. It has been cited 95 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5I01BX004033-03
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease
National Institutes of Health
Grant: 1IS1BX004777-01
The ShEEP request for Waters Xevo TQ-XS Liquid Chromatography Mass Spectrometer System
National Institutes of Health
Grant: 5IK6BX004477-02
BLR&D Research Career Scientist Award Application
National Institutes of Health
Grant: 5R21AA026629-02
Sphingosine-1 phosphate signaling in alcoholic liver disease
National Institutes of Health
Grant: 5R01DK104893-02
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis
National Institutes of Health
Grant: 5R01DK057543-02
BILE ACID SIGNALING &HEPATIC CHOLESTEROL METABOLISM
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Simultaneous determination of seven bile acids to study the effect of ivermectin on their plasma levels in rat by UHPLC–MS/MS
Additional file 1 of Simultaneous determination of seven bile acids to study the effect of ivermectin on their plasma levels in rat by UHPLC–MS/MS